Foundation Medicine: Sanket Angrawal

Foundation Medicine announced that it has appointed Sanket Agrawal as its chief biopharma business officer. Agrawal will lead and expand the company's set of collaborations with biotech and pharmaceutical partners to support the development of innovative cancer treatments.

He previously served at Amgen in roles related to research and development and commercial oncology, and as a general manager. He led the development of sotorasib (Amgen's Lumakras), a targeted therapy for patients with non-small cell lung cancer driven by any KRAS mutation. 

Earlier in his career, he held leadership positions at Oracle Health Sciences (formerly Relsys) and management consultant firms.